The addition of Asepco, a Mountain View, California-based aseptic processing equipment firm, will form a “natural extension” to the product portfolio of pump and fluid-path technology firm Watson-Marlow Fluid Technology Group, the company said.
“The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow's position in the biopharmaceutical market,” President of Watson-Marlow Jay Whalen said.
“This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path.”
Asepco’s product lines include stainless steel valves, diaphragms, actuators, magnetic mixers and connectors, used in both the biopharmaceutical processing.
These will be added to Watson-Marlow’s product range comprising of pumps, tubing, filling systems, and tubing connector systems.
The news comes 15 months after Watson-Marlow shelled out a similar amount (£8.5m) to buy single-use connection developer Bio Pure Technology.